BioDuro-Sundia Appoints Dr. Armin Spura As CEO
16 Sep 2024 //
BUSINESSWIRE
BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award
03 Apr 2023 //
BUSINESSWIRE
BioDuro-Sundia Announces Formation of Scientific Advisory Board
27 Mar 2023 //
BUSINESSWIRE
BioDuro-Sundia Expands Drug Discovery Capacity and Capability
13 Feb 2023 //
BUSINESSWIRE
BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services
07 Aug 2022 //
BUSINESSWIRE
BioDuro-Sundia Appoints Kent Payne CEO
17 Feb 2022 //
BUSINESSWIRE
BioDuro-Sundia Acquires Solid Dose Manufacturing Facility
31 Aug 2021 //
CONTRACT PHARMA
BioDuro-Sundia plants its flag at former Par manufacturing site in CA
26 Aug 2021 //
ENDPTS
BioDuro-Sundia Acquires US-based Phase III Drug Product Manufacturing Facility
23 Aug 2021 //
BUSINESSWIRE
BioDuro & Sundia Partner as an Industry Leading CRDMO
24 Sep 2020 //
BUSINESSWIRE
New Preclinical Models for NASH Provide Strong Clinical Relevance
26 May 2020 //
BUSINESSWIRE
BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform
28 Apr 2020 //
BUSINESSWIRE
BioDuro Chooses SciFinder-n From CAS
18 Nov 2019 //
CONTRACT PHARMA